iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Get Free Report) were up 0.2% on Thursday . The stock traded as high as $38.36 and last traded at $38.31. Approximately 6,081 shares were traded during mid-day trading, an increase of 121% from the average daily volume of 2,756 shares. The stock had previously closed at $38.22.
iShares LifePath Target Date 2065 ETF Trading Down 0.9%
The firm has a market capitalization of $16.70 million, a price-to-earnings ratio of 20.19 and a beta of 0.87. The firm has a 50 day moving average price of $37.48 and a two-hundred day moving average price of $35.94.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in iShares LifePath Target Date 2065 ETF stock. Heck Capital Advisors LLC boosted its position in shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Free Report) by 30.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,897 shares of the company’s stock after purchasing an additional 1,381 shares during the quarter. Heck Capital Advisors LLC owned 1.73% of iShares LifePath Target Date 2065 ETF worth $203,000 as of its most recent SEC filing.
About iShares LifePath Target Date 2065 ETF
The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Featured Stories
- Five stocks we like better than iShares LifePath Target Date 2065 ETF
- Earnings Per Share Calculator: How to Calculate EPS
- Why Amazon Could Be a $300 Stock Within Weeks
- What is a Dividend King?
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- What to Know About Investing in Penny Stocks
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
